These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 789414)

  • 1. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
    Radó JP; Marosi J; Fischer J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J; Borbély L; Takó J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
    Radó JP; Marosi J; Fischer J; Takó J; Kiss N
    Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lengthening of the duration of action of DDAVP by "ineffective" doses of clofibrate in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J
    Endokrinologie; 1976 Jun; 67(2):220-9. PubMed ID: 954691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
    Hammer M; Vilhardt H
    J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidus.
    Radó JP; Marosi J; Fischer J
    Pharmacology; 1977; 15(1):40-5. PubMed ID: 840889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
    Czakó L; Julesz J; László FA
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of DDAVP in cranial diabetes insipidus as compared to other antidiuretic drugs.
    Coculescu M; Antipa C; Cucu C
    Endocrinologie; 1977; 15(4):275-81. PubMed ID: 563614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
    Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDAVP in the treatment of central diabetes insipidus.
    Robinson AG
    N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-desamino-8-D-arginine vasopressin (DDAVP) concentration test.
    Radó JP
    Am J Med Sci; 1978; 275(1):43-52. PubMed ID: 665711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
    Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
    Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F; Mezei G; Julesz J; Lázló FA
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term treatment of central diabetes insipidus with oral DDAVP].
    Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
    Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of vasopressin analogue DDAVP in patients with postoperative diabetes insipidus (author's transl)].
    Kubota T; Kashiwara K; Ito H; Tani K; Yamamoto S
    No To Shinkei; 1981 Jun; 33(3):617-23. PubMed ID: 7259900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year experience with DDAVP in treatment of diabetes insipidus.
    Marek J; Loutocký A; Pacovský V; Zaoral M
    Endokrinologie; 1978 May; 72(2):188-94. PubMed ID: 738214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.